ZIKANI THERAPEUTICS
Zikani Therapeutics are among the most widely used, most effective, and safest antibiotics to reach clinical practice; in fact, azithromycin has been among the world’s most widely used antibiotics for the past several years. But, while current macrolides are highly effective against some major bacteria, they are ineffective against others, especially gram-negative bacteria, the cause of most serious infections in the US. The first three generations of macrolides have very limited activity ag... ainst gram-negative, and the sole drug in the current fourth-generation, solithromycin, has only slightly greater activity. Within other antibiotic classes, a limited number of compounds are in development to treat resistant gram-negative infections, and even fewer are available both intravenously and orally, as would be expected with macrolides. The company was founded in 2014 and is headquartered in Newton, Massachusetts.
ZIKANI THERAPEUTICS
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2014-01-01
Address:
Newton, Massachusetts, United States
Country:
United States
Website Url:
http://www.zikani.com
Total Employee:
11+
Status:
Active
Contact:
+1 617 645 4982
Email Addresses:
[email protected]
Total Funding:
56.3 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS Google Google Maps API Google Cloud Barracuda Networks Dreamhost DNS
Current Advisors List
Current Employees Featured
Founder
Investors List
Roche Venture Fund
Roche Venture Fund investment in Series A - Zikani Therapeutics
Advent Life Sciences
Advent Life Sciences investment in Series A - Zikani Therapeutics
SR One
SR One investment in Venture Round - Zikani Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Venture Round - Zikani Therapeutics
Advent Life Sciences
Advent Life Sciences investment in Venture Round - Zikani Therapeutics
Roche Venture Fund
Roche Venture Fund investment in Venture Round - Zikani Therapeutics
CARB-X
CARB-X investment in Grant - Zikani Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series A - Zikani Therapeutics
Roche Venture Fund
Roche Venture Fund investment in Series A - Zikani Therapeutics
SR One
SR One investment in Series A - Zikani Therapeutics
Official Site Inspections
http://www.zikani.com
- Host name: ec2-34-205-242-146.compute-1.amazonaws.com
- IP address: 34.205.242.146
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
